Kimia Biosciences Ltd
₹36.50
(0.82%)
Sun, 31 May 2026, 03:13 am
Health Technology
Pharmaceuticals: Major
24.5KKimia Biosciences Share Price Live Chart
1 Day
(0.82%)
No Result Found
Summary
Market Cap
172.69
Net Profit
9.61
P/B
20.15
Sector P/E
44.89
P/E
20.94
EV/EBITDA
10.82
Debt/Equity (Industry)
0.17
Interest Cover (Industry)
18.17
ROCE (Industry)
20.59
RONW (Industry)
17.62
ROE
172.53
ROCE
34.57
Debt/Equity
7.46
EPS (TTM)
1.91
Dividend Yield
0
Book Value
2.45
Interest Cover
3.99
Analysis
all
- Kimia Biosciences is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Kimia Biosciences is profitable, therefore cash runway is not a concern.
- Kimia Biosciences is profitable, therefore cash runway is not a concern.
- Debt is covered by short term assets, assets are 1.8x debt.
- Kimia Biosciences's cash and other short term assets cover its long term commitments.
- Unable to evaluate Kimia Biosciences's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Kimia Biosciences's dividend against the top 25% market benchmark as the company has not reported any payouts.
- Operating cash flow is negative therefore debt is not well covered.
- The level of debt compared to net worth has increased over the past 5 years (100.2% vs 230.4% today).
- Interest payments on debt are not well covered by earnings (EBIT is 2.3x annual interest expense, ideally 3x coverage).
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 74.94 | 74.94 | 74.94 | 74.94 | 74.94 |
| FII | 0 | 0 | 0 | 0 | 0 |
| DII | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 |
| Public | 24.68 | 24.68 | 24.68 | 24.68 | 24.68 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 65.75 | 49.34 | 42.27 | 32.93 | 25.86 | 16.52 | 0.11 |
| Fibonacci | 49.34 | 43.07 | 39.20 | 32.93 | 26.66 | 22.79 | 16.52 |
| Camarilla | 39.71 | 38.21 | 36.70 | 32.93 | 33.70 | 32.19 | 30.69 |
Pivots Level: Classic
R3
+32.82
65.75
R2
+16.41
49.34
R1
+9.34
42.27
S1
-7.07
25.86
S2
-16.41
16.52
S3
-32.82
0.11
Moving Average
Period
Value
10-EMA
36.18
20-EMA
35.98
30-EMA
35.54
50-EMA
34.71
100-EMA
34.13
200-EMA
35.84
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 29 May 2026 | board-meetings | Accounts | |
| 14 Feb 2026 | board-meetings | Quarterly Results, Nine Months Results | |
| 14 Nov 2025 | board-meetings | Quarterly Results | |
| 29 Aug 2025 | agm | ||
| 25 Jun 2025 | egm | ||
| 05 Dec 2024 | agm | ||
| 02 Sept 2023 | agm | ||
| 23 Sept 2022 | agm | ||
| 28 Aug 2021 | agm |
Peer Comparison
Kimia Biosciences Ltd
Cipla Ltd
Divis Laboratories Ltd
Torrent Pharmaceuticals Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Kimia Biosciences Ltd About
Kimia Biosciences main objective of the Company is to carry on business of Pharamaceutical products.
Industry
Pharmaceuticals - Indian - Bulk Drugs
Founded
1993
Headquarters
CEO
Sameer Goel
Employees
Contact
Website
http://www.kimiabiosciences.com
compliance.kimia@gmail.com
Phone
91-11-29535650
Location
Bhondsi Village, Tehsil Sohna, Gurgaon, Haryana, 122102
Kimia Biosciences Ltd Company History
| Year | History |
|---|---|
| 1993 |
|
| 2017 |
|
| 2019 |
|
| 2024 |
|